Calcium Carbonate 500mg + Calcitriol 0.25mcg + Zinc 7.5mg + Vitamin K2-7 45 mcg + Methylcobalamin 1500mcg + L-methylfolate 800mcg Soft Gel Capsules is a softgel dosage form which is a multi-component product of mineral component and some vitamins and micronutrient ingredients. This formulation is a multisource formulation that is particular softgel oral dosage form requiring on the controlled form to be mixed to be incorporated, weighed with precision, fill levels evenly filled and full-time protective.
The formula, which has -calcium carbonate 500 mg, calcitriol 0.25 mcg, zinc 7.5 mg, k 2 -7 45 mcg, methylcobalamin 1500 g and L methylfolate 800 g contains calcium carbonate 500 mg, calcitriol 0.25 mcg, zinc 7.5 mg, k 2 -7 45 mcg, methylcobalamin 1500 g and L methylfolate 800 g. Each of these components is present in a relatively unique volume.
What is Softgel Technology? Softgel is a unique dosage form platform that encapsulates a formulation fill in a flexible softgel capsule. If you are a pharma company with a new nutritional formulation, it can add to your existing product portfolio by availing of this product with a PCD Pharma Franchise.
For example, the formulation contains six API's with varying physiochemical properties. Calcium Carbonate 500 mg is the predominant mineral and is likely to substantially impact fill viscosity, suspension properties, as well as the total amount of formulation in the softgel system.
Calcitriol 0.25 mcg is present at a very low level. So precise measurement, strict premixing prior to blending, and proper analytical validation become very critical. The manufacturing of the formulation must facilitate the all-over blending of such low dose component.
Zinc 7.5 mg is included by way of pharmaceutical form allowance, and Vitamin K2-7 45 mcg may need to be added in an appropriate pharmaceutical form. Methylcobalamin 1500 mcg and L-Methylfolate 800 mcg contribute additional low-dose vitamin ingredients.
The softgel fill, depending on the formulation, can also contain the aforementioned appropriate oils, suspending agents, stabilizers, viscosity modifiers or other functional excipients. Pre-formulation testing will determine the compatibility of active ingredients and fill substances with the softgel shell.
How to manufacture: Step1-Receiving of raw material Pharma-grade raw materials shall be received and checked against related document mentioned on the packaging. Manufacturing Calcium Carbonate 500 mg + Calcitriol 0.25 mcg + Zinc 7.5 mg + Vitamin K2-7 45 mcg + Methylcobalamin 1500 mcg + L-Methylfolate 800 mcg Soft Gel Capsules.
The ingredients are weighed out individually as per the batch formula approved. 500mg of calcium carbonate vastly outweighs ingredients that are measured in the micrograms and the use of controlled premix or geometric dilution methods might be implemented to reach optimal uniformity.
The characterized liquid vehicle and functional excipients are standardized. Solid ingredients may be previously ground, pre blended, or screened. Mixing parameters (agitation rate, processing temperature, processing duration, and manner of addition) are determined during formulation development.
The prepared fill material may be kept under constant agitation to prevent settling and to maintain homogeneity prior to capping. It is subsequently deposited into proprietary softgel encapsulation equipment.
Encapsulation Enclose the fill within capsule-shell ribbons of appropriate composition. Monitor-fill weight, ribbon thickness, sealing temperature, capsule shell and machine speed. After encapsulation, a controlled drying cycle is used to develop the appropriate shell characteristics and residual moisture profile.
Ensuring product quality is especially important for a multi-ingredient formulation where ingredients are present at mg and ug level. The softgel capsules of Calcium Carbonate 500 mg + Calcitriol 0.25 mcg + Zinc 7.5 mg + Vitamin K2-7 45 mcg + Methylcobalamin 1500 mcg + L-Methylfolate 800 mcg are to be manufactured with suitable test methods for individual ingredients as well as finished-product quality.
Testing may include identification and assay, uniformity of dosage units, fill-weight variation, capsule appearance, dimensions, disintegration, and other relevant characteristics.
Microgram ingredients, in particular calcitriol and Vitamin K2-7, need to be afforded an appropriate analytical sensitivity and representative sampling. Established validated analytical procedures are necessary in order to monitor these ingredients in a complex matrix, such as formulation.
For CaCO3 and zinc, appropriate validated laboratory testing methods can be applied to measure the recommended content. Methylcobalamin and L-methylfolate can be measured using appropriate methods as well.
The types of quality checks specific to softgels could also include leakage, the quality of the seal, the look of the shells, deformed shells, sticking, fill quality, and dimension of the shell. Additional quality checks can be applied to fill preparation and encapsulation during manufacture.
A stability testing program is an essential component of the development of such a multi-component softgel formulation. The program can evaluate the capsule shell externally and the formulation internally against predetermined environmental factors.
A number of other parameters could be relevant including assay of individual ingredients, properties related to stability, appearance, uniformity of fill, integrity of shells, disintegration and other quality characteristics relating to formulation. Particular attention may be paid to the stability of ingredients present at low concentrations and the compatibility of these with the chosen fill system.
The pack will need to protect the product from the adverse environmental conditions, at least during the storage and transportation. It will be placed in a blister strip, alu-alu blister pack or pharmaceutical grade bottles, according to the defined specification.
The packaging system chosen should ensure the integrity of the capsule and be suitably protective against moisture, light, oxygen and temperature, where appropriate. Compatibility of container and closure can be assessed at a later stage of the development process.
The label on the finished pack must show the product name, full composition, strength, batch number, date of manufacture, expiry date, pack size, storage conditions, other relevant regulatory requirements and other essential information.
Calcium Carbonate 500 Mg + Calcitriol 0.25 Mcg + Zinc 7.5 Mg + Vitamin K2-7 45 Mcg + Methylcobalamin 1500 Mcg + L-Methylfolate 800 Mcg Soft Gel Capsules, can be cast as a niche multi-component formulation in the portfolio of pharmaceutical and nutritional products. It involves a combination of mineral and vitamin/micronutrient ingredients and demands a higher degree of formulation synchronization than the more uncomplicated single-nutrient products.
Introduction of Different Softgel Variants to your Portfolio If you are a PCD Pharma Franchise Company and exploring diversification of your product list, then different softgel formulas can help you reach your objective. Franchisee Product PCD Franchise.
The process cycle for the manufacturing is raw-material qualification, dispensing; precise weighing, premix preparation (premix control), fill preparation (fill preparation control), encapsulation, drying, quality testing, stability testing, and final packaging. This process has process controls specified at each step as well as QC procedures.
For Consistent Batch Manufacturing and Portfolio Integration With an intricately defined dose-specified blend of Calcium Carbonate, Calcitriol, Zinc, Vitamin K2-7, Methylcobalamin, and L-Methylfolate, this softgel type can be packaged under a quality-driven strategy for dose uniformity, accuracy at low dosages, fill stability, capsule strength, analytical consistency, and professional product appearance. This product can be made with integrated quality control and manufacturing for a professional pharmaceutical portfolio.
We combine quality, innovation, and strong distribution to help our partners grow successfully in the pharma market.
The company is offering business opportunity for scalable and sustainable returns to its associates. We are engaged in discovery, development and commercialization of pharmaceutical medicine keeping in mind its quality and affordability.
© Novolilly 2025. All Rights Reserved – Developed & Managed By Kavir Infotech